Finance

Lists
300601:SHE
Shenzhen Kangtai Biological Prods Co Ltd
12,43 CN¥
-0,56%
(-0,070) 1D
16 қаз., 15:04:19 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300601...
Open
12,59 CN¥
High
13,00 CN¥
Low
12,30 CN¥
Mkt. cap
13,88 млрд
Avg. vol.
19,76 млн
Volume
20,15 млн
P/E ratio
165,53
52-wk high
17,76 CN¥
52-wk low
10,70 CN¥
EPS
0,08 CN¥
Shares outstanding
1,12 млрд
No. of employees
2 мың
Open
12,59 CN¥
High
13,00 CN¥
Low
12,30 CN¥
Mkt. cap
13,88 млрд
Avg. vol.
19,76 млн
Volume
20,15 млн
P/E ratio
165,53
52-wk high
17,76 CN¥
52-wk low
10,70 CN¥
EPS
0,08 CN¥
Shares outstanding
1,12 млрд
No. of employees
2 мың
News stories
From web sources and news partners
Profile
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products. Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
About Shenzhen Kangtai Biological Prods Co Ltd
CEO-
Employees1,96 мың
Founded1992 ж. 08 қыр.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
671,38 млн
609,64 млн
631,11 млн
641,89 млн
Cost of goods sold
110,97 млн
267,74 млн
182,40 млн
218,78 млн
Cost of revenue
110,97 млн
267,74 млн
182,40 млн
218,78 млн
Research and development expenses
123,15 млн
123,35 млн
84,28 млн
90,88 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
291,37 млн
283,35 млн
302,79 млн
284,34 млн
Operating expense
425,29 млн
428,59 млн
406,24 млн
402,08 млн
Total operating expenses
536,26 млн
696,33 млн
588,65 млн
620,87 млн
Operating income
135,12 млн
-86,69 млн
42,47 млн
21,03 млн
Other non operating income
-375,71 м.
308,38 м.
-2,04 млн
1,69 млн
EBT including unusual items
324,22 м.
45,26 млн
39,95 млн
1,37 млн
EBT excluding unusual items
125,91 млн
-104,26 млн
19,66 млн
-1,09 млн
Income tax expense
-11,26 млн
24,17 млн
6,35 млн
-12,75 млн
Effective tax rate
-3 472,08%
53,40%
15,89%
-932,00%
Other operating expenses
3,89 млн
14,05 млн
6,96 млн
12,14 млн
Net income
11,62 млн
21,17 млн
33,34 млн
17,05 млн
Net profit margin
1,73%
3,47%
5,28%
2,66%
Earnings per share
-
-
-
-
Interest and investment income
20,88 млн
13,75 млн
8,72 млн
9,41 млн
Interest expense
-30,13 млн
-30,16 млн
-29,50 млн
-29,76 млн
Net interest expenses
-9,24 млн
-16,42 млн
-20,77 млн
-20,35 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
212,79 млн
11,74 млн
140,90 млн
126,83 млн
Gain or loss from assets sale
-365,90 м.
934,47 м.
-
-5,69 мың
AI content may include mistakes. Learn more
Google қолданбалары